User: Guest  Login
Title:

Safety profile of chloroquine and hydroxychloroquine: a disproportionality analysis of the FDA Adverse Event Reporting System database.

Document type:
Article; Comparative Study; Journal Article
Author(s):
Papazisis, G; Siafis, S; Cepatyte, D; Giannis, D; Stamoula, E; Tzachanis, D; Egberts, T
Abstract:
OBJECTIVE: The present study aims to identify potential safety signals of chloroquine (CQ) and hydroxychloroquine (HCQ), over the period preceding their repurpose as COVID-19 treatment options, through the analysis of safety data retrieved from the FDA Adverse Event Reporting System (FAERS) pharmacovigilance database. MATERIALS AND METHODS: We performed a disproportionality analysis of FAERS data between the first quarter of 2004 and December 2019 using the OpenVigil2.1-MedDRA software. Dispropo...     »
Journal title abbreviation:
Eur Rev Med Pharmacol Sci
Year:
2021
Journal volume:
25
Journal issue:
19
Pages contribution:
6003-6012
Fulltext / DOI:
doi:10.26355/eurrev_202110_26878
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/34661260
Print-ISSN:
1128-3602
TUM Institution:
Klinik und Poliklinik für Psychiatrie und Psychotherapie
 BibTeX